How to Cure Diabetes and Get Off Insulin
December 19th, 2009 admin
Here’s a guest post on how someone got off insulin and cure diabetes in about 2 months after nine years on prescription drugs! And if only she’d known about this “blood sugar supplement” she could have prevented the whole problem before it ever started! June was a 56-year-old with diabetes. She had been on insulin and oral prescription medications for nine years when she agreed to test a new natural solution. Within six weeks, she stopped not only her insulin but another prescription drug as well. Want to Learn How To Cure Diabetes? Read This… In just six weeks an alternative doctor solved a problem that mainstream medicine couldn’t handle in nine years and for thousands of dollars. The fact is that it costs the typical diabetic around…

Related Posts
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits-known as the “doughnut hole” – have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms. Surprisingly, generic-only drug plans to cover the...
My road to diagnosis began with an infection; a yeast infection to be exact. That’s right, I, a male, had a yeast infection. Now, I’m like most guys when it comes to the plumbing, and was rather embarrassed by the fact that something was wrong downstairs. And, like an idiot, I delayed going to the doctor by trying “home remedies” first, in...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced that the paper entitled, “Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects,” authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of alternative drug delivery systems, reported results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801. The randomized, double-blind, placebo-controlled, multi-centered study conducted in South Africa evaluated responses of 29 Type 2 diabetes...
Diabetes is becoming a major problem in the world and it is growing which is forcing the diabetes community to make some quick judgements: Prevent diabetes from ever occuring. Develop the cure to diabetes. Or take care of the people who have it in order to prevent complications. All three approaches are actively being pursued by the National Institutes...
A hormone responsible for the body’s stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure...
Entelos, Inc. has announced a publication in the peer-reviewed journal Clinical and Experimental Immunology describing the Type 1 Diabetes (T1D) PhysioLab® platform, an in silico solution for rapidly streamlining preclinical research through the evaluation of alternative scenarios for therapeutic strategies…
Read More →
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That’s among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical &...
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents…
Read More →
When you go to the doctor, do you go prepared with a list of questions for the doctor? That was one of the questions during last weeks DSMA session on Twitter.
Read More →
Related Tweets from Twitter
Related News from Digg